close menu
Bookswagon-24x7 online bookstore
close menu
My Account
Carlos A. Zarate

Carlos A. ZarateDr. Zarate completed his residency training in psychiatry at the Massachusetts Mental Health Center/Brockton VAMC division. He later completed a fellowship in Clinical Psychopharmacology at McLean Hospital of the Consolidated Department of Psychiatry Harvard Medical School and remained on staff at McLean Hospital as the Director of the Bipolar and Psychotic Disorders Outpatient Services. From 1998 to 2000 Dr. Zarate was the Chief of the Bipolar and Psychotic Disorders Program at the University of Massachusetts Medical School. In 2001, he joined the Mood and Anxiety Disorders Program at NIMH. His achievements and awards include the Ethel-DuPont Warren Award and Livingston Awards, Consolidated Department of Psychiatry, Harvard Medical School; Outstanding Psychiatrist Research Award, Massachusetts Psychiatric Association; Program for Minority Research Training in Psychiatry, APA; the National Alliance for Research on Schizophrenia and Depression Young Investigator Award; National Alliance for Research on Schizophrenia and Depression Independent Investigator Award; the National Institutes of Health Director’s Award Scientific/Medical, the 2011 Brain & Behavior Research Foundation Award for Bipolar Mood Disorder Research, the 2013 National Institute of Health Director’s Award—Scientific/Medical Achievement and Mogens Schou Research Award: Bipolar Disorder and the Simon-Bolivar Award American Psychiatric Association; 2015 Ruth L. Kirschtein Mentoring Award NIH and the Astute Clinician Lecture Award, NIH; the 2019 ACNP Dolores Shockley Minority Mentoring Award; and in 2019 was promoted to NIH Distinguished Investigator, NIMH, NIH. Dr. Zarate is a fellow of the American College of Neuropsychopharmacology and member of the Society of Biological Psychiatry and the Society for Neuroscience. Dr. Zarate’s research focuses on the pathophysiology and development of novel therapeutics for treatment-resistant mood disorders as well as the study of biomarkers and neural correlates of treatment response. Read More Read Less

9 results found
List viewGrid view
Sort By:
1.
Ketamine for Treatment-Resistant Depression21 %
No Review Yet
₹12,264
₹9,689
Binding:
Hardback
Release:
15 Dec 2016
Language:
English
Available
Ships within 14-16 Days Explain..
2.
Ketamine for Treatment-Resistant Depression45 %
No Review Yet
₹9,350
₹5,143
Binding:
Paperback
Release:
18 Sep 2020
Language:
English
Available
Ships within 14-16 Days Explain..
3.
Neurobiology of Depression45 %
No Review Yet
₹14,025
₹7,714
Binding:
Paperback
Release:
08 Jan 2019
Language:
English
Available
Ships within 14-16 Days Explain..
4.
Ketamine for Treatment-Resistant Depression21 %
No Review Yet
₹10,034
₹7,927
Binding:
Paperback
Release:
07 Jul 2018
Language:
English
Available
Ships within 14-16 Days Explain..
5.
Behavioral Neurobiology of Bipolar Disorder and its Treatment37 %
No Review Yet
₹22,299
₹14,048
Binding:
Hardback
Release:
11 Nov 2010
Language:
English
Available
Ships within 14-16 Days Explain..
6.
Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy37 %
Available
Ships within 14-16 Days Explain..
7.
Behavioral Neurobiology of Bipolar Disorder and its Treatment37 %
No Review Yet
₹22,299
₹14,048
Binding:
Paperback
Release:
02 Jan 2013
Language:
English
Available
Ships within 14-16 Days Explain..
8.
Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy37 %
Available
Ships within 14-16 Days Explain..
9.
Bipolar Depression
Publisher: Springer
No Review Yet
₹2,201
Binding:
Paperback
Release:
12 May 2009
Language:
English
Out of Stock
Notify me when this book is in stockNotify Me
No more records found
ASK VIDYA